Clinical Trial Update: Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

View source ↗

Summary

This clinical trial update describes a dual antiplatelet optimized stent intended for patients with high bleeding risk undergoing stent implantation; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University Hospital, Grenoble | Conditions: High Bleeding Risk Patients, Cardiology | Status: NOT_YET_RECRUITING